EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recent Update on Management of Xerostomia: A Narrative Review

Olawande Adebayo, Funmilola Eunice Adewinle, Elijah Olufemi Oyetola

Nigerian Dental Journal · 17.06.2026 · 34 (2)

DOI: 10.61172/511phg61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nigerian Dental Journal, online erschienen am 17.06.2026. Verfasst von Olawande Adebayo und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xerostomia is a multifactorial condition with significant consequences for oral function and quality of life. While conventional diagnostic and treatment strategies remain essential, rapid advances in salivary diagnostics, imaging technologies, artificial intelligence, and regenerative therapies have expanded the clinical landscape. However, the clinical utility and translational readiness of these emerging approaches remain incompletely synthesised.

Objectives

To review conventional and emerging diagnostic and therapeutic approaches for xerostomia and evaluate their clinical utility, translational readiness, and limitations.

Methods

A narrative literature review was conducted using Google Scholar, MEDLINE, and PubMed databases. English-language publications from 2000 to 2025 were retrieved using combinations of keywords related to xerostomia, diagnosis, management, biomarkers, imaging, and emerging therapies. Clinical studies, systematic reviews, meta-analyses, and relevant narrative reviews were included.

Results

Conventional diagnostic methods, including symptom assessment, clinical examination, and sialometry, remain essential but have limitations. Emerging approaches such as salivary biomarkers, advanced imaging, wearable sensors, and artificial intelligence show improved diagnostic potential. Traditional treatments focus on symptom relief and salivary stimulation, while novel therapies—including acupuncture, low-level laser therapy, intraoral devices, and regenerative approaches—demonstrate promising outcomes. However, their clinical application is limited by cost, accessibility, and insufficient validation.

Conclusion

Conventional and emerging approaches should be viewed as complementary rather than competing strategies in xerostomia management. Although novel technologies offer substantial promise for improving diagnostic precision and therapeutic outcomes, further clinical validation and long-term evidence are required before widespread integration into routine practice. Keywords: Xerostomia; Hyposalivation; Salivary gland dysfunction; Diagnosis; Salivary biomarkers; Emerging therapies

Zitieren

APA

Adebayo, O., Adewinle, F. E., & Oyetola, E. O. (2026). Recent Update on Management of Xerostomia: A Narrative Review. Nigerian Dental Journal, 34(2). https://doi.org/10.61172/511phg61

Vancouver

Adebayo O, Adewinle FE, Oyetola EO. Recent Update on Management of Xerostomia: A Narrative Review. Nigerian Dental Journal. 2026;34(2). doi:10.61172/511phg61

BibTeX
@article{Adebayo2026,
  author = {Adebayo, Olawande and Adewinle, Funmilola Eunice and Oyetola, Elijah Olufemi},
  title = {Recent Update on Management of Xerostomia: A Narrative Review},
  journal = {Nigerian Dental Journal},
  year = {2026},
  volume = {34},
  number = {2},
  doi = {10.61172/511phg61}
}
Kostenlos starten →